Aileron Therapeutics Inc at Emerging Growth Conference Transcript
Welcome back, everyone. Next up, we have Aileron Therapeutics, Inc. It trades on the NASDAQ under the symbol ALRN and is a clinical stage chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patients. Please welcome its CEO, Manuel Aivado. Welcome, Manuel.
Thank you, Ana. Thanks for the invite. Pleasure to be here. As Ana said, my name is Manuel Aivado, and I'm the President and CEO of Aileron Therapeutics. By background, I'm a medical oncologist with 25 years' experience in treating patients as well as developing drugs in the drug developing industry.
In the coming presentation, I will be making forward-looking statements as stated here on the slides that can be found on our website. And if I had to summarize the entire story of our company in one slide, this would be the slide.
What we do at Aileron is that we aspire to transform chemotherapy. We want to make chemotherapy a well
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |